Lindbrook Capital’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-538
Closed -$5.64K 2778
2023
Q4
$5.64K Sell
538
-35
-6% -$429 ﹤0.01% 1825
2023
Q3
$7.53K Sell
573
-2
-0.3% -$26 ﹤0.01% 1554
2023
Q2
$7.25K Buy
575
+504
+710% +$6.12K ﹤0.01% 1635
2023
Q1
$927 Buy
71
+34
+92% +$551 ﹤0.01% 2466
2022
Q4
$653 Hold
37
﹤0.01% 2540
2022
Q3
$1K Sell
37
-43
-54% -$695 ﹤0.01% 2562
2022
Q2
$1K Buy
+80
New +$1.5K ﹤0.01% 2430

Other funds holding MDRX

Lindbrook Capital's MDRX Position: Q1 2024 in Review

Lindbrook Capital sold out of Veradigm Inc. Common Stock (MDRX) in Q1 2024, closing a stake of 538 shares — an estimated $5.64K sold.

Lindbrook Capital first reported a position in MDRX in Q2 2022 and held it in 7 quarters. The position peaked at $7.53K in Q3 2023. 35 funds tracked by Wall St. Rank hold MDRX as of Q1 2024.

  • Lindbrook Capital reported no remaining Veradigm Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Lindbrook Capital sold 538 Veradigm Inc. Common Stock shares in Q1 2024, an estimated $5.64K.
  • Lindbrook Capital first reported a position in Veradigm Inc. Common Stock in Q2 2022 and held it in 7 quarters.
  • Lindbrook Capital's Veradigm Inc. Common Stock position peaked at $7.53K in Q3 2023.
  • 35 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q1 2024.

Based on Lindbrook Capital's 13F filing for Q1 2024, filed 25 Apr 2024.